Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype.
Nassiri F, Ajisebutu A, Patil V, Mamatjan Y, Liu J, Wang JZ, Voisin MR, Nejad R, Mansouri S, Karimi S, Chakravarthy A, Chen E, De Carvalho DD, Aldape K, Zadeh G.
Nassiri F, et al. Among authors: mansouri s.
Acta Neuropathol. 2024 Apr 7;147(1):68. doi: 10.1007/s00401-024-02713-1.
Acta Neuropathol. 2024.
PMID: 38583102